Literature DB >> 6847869

On the role of dopamine receptors in the naloxone-induced hormonal changes in man.

G Delitala, L Devilla, N R Musso.   

Abstract

To assess the role of dopamine receptors in naloxone-induced hormonal changes, the effects of dopamine and metoclopramide on anterior pituitary hormone secretion were studied during the infusion of the opiate blocker in normal men. Naloxone stimulated LH and cortisol secretion in all subjects, whereas FSH, TSH, PRL, and GH did not change. The infusion of dopamine completely suppressed the naloxone-induced LH rise; on the contrary, metoclopramide failed to alter the magnitude of the increments in LH observed during the infusion of the opiate blocker. The cortisol response to naloxone remained unchanged during dopamine and metoclopramide infusion. Metoclopramide stimulated PRL and TSH release during naloxone treatment, whereas dopamine suppressed PRL and TSH secretion. The data do not suggest a participation of dopamine receptors in the naloxone-induced hormonal changes in man and confirm a suppressive effect of dopamine infusion on LH release in humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847869     DOI: 10.1210/jcem-56-1-181

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man.

Authors:  D Esposti; P Lissoni; R Mauri; F Rovelli; L Orsenigo; S Pescia; G Vegetti; G Esposti; F Fraschini
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

Review 2.  Effects of opioids on the parental brain in health and disease.

Authors:  James E Swain; S Shaun Ho; Helen Fox; David Garry; Susanne Brummelte
Journal:  Front Neuroendocrinol       Date:  2019-05-22       Impact factor: 8.606

3.  Serum concentrations of PRL, GH, LH, FSH, TSH and cortisol after single administration to man of a new synthetic narcotic analgesic butorphanol.

Authors:  E Rolandi; R Franceschini; A Marabini; V Messina; T Barreca
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.